REFERENCES
- Torchilin V.P., Rammohan R., Weissig V., Levchenko T.S. TAT Peptide on the Surface of Liposomes Affords their Efficient Intracellular Delivery Even at Low Temperature and in the Presence of Metabolic Inhibitors. Proc. Natl. Acad. Sci. USA 2001; 98: 8786–8791
- Matlin K.S., Reggio H., Helenius A., Simons K. Infectious Entry Pathway of Influenza Virus in a Canine Kidney Cell Line. J. Cell. Biol. 1981; 91: 601–613
- Yoshimura A., Ohnishi S. Uncoating of Influenza Virus in Endosomes. J. Virol. 1984; 51: 497–504
- Ramalho-Santos J., Pedroso de Lima M.C. The Influenza Virus Hemagglutinin: A Model Protein in the Study of Membrane Fusion [In Process Citation]. Biochim. Biophys. Acta 1998; 1376: 147–154
- Wiley D.C., Skehel J.J. The Structure and Function of the Hemagglutinin Membrane Glycoprotein of Influenza Virus. Annu. Rev. Biochem. 1987; 56: 365–394
- Nussbaum O., Lapidot M., Loyter A. Reconstitution of Functional Influenza Virus Envelopes and Fusion with Membranes and Liposomes Lacking Virus Receptors. J. Virol. 1987; 61: 2245–2252
- Stegmann T., Morselt H.W., Booy F.P., van Breemen J.F., Scherphof G., Wilschut J. Functional Reconstitution of Influenza Virus Envelopes. EMBO J. 1987; 6: 2651–2659
- Almeida J.D., Edwards D.C., Brand C.M., Heath T.D. Formation of Virosomes from Influenza Subunits and Liposomes. Lancet 1975; 2: 899–901
- Bron R., Ortiz A., Wilschut J. Cellular Cytoplasmic Delivery of a Polypeptide Toxin by Reconstituted Influenza Virus Envelopes (Virosomes). Biochemistry 1994; 33: 9110–9117
- Waelti E.R., Gluck R. Delivery to Cancer Cells of Antisense l-Myc Oligonucleotides Incorporated in Fusogenic, Cationic-Lipid-Reconstituted Influenza-Virus Envelopes (cationic virosomes). Int. J. Cancer 1998; 77: 728–733
- Arkema A., Huckriede A., Schoen P., Wilschut J., Daemen T. Induction of Cytotoxic T Lymphocyte Activity by Fusion-Active Peptide-Containing Virosomes. Vaccine 2000; 18: 1327–1333
- Matsumoto T. Membrane Destabilizing Activity of Influenza Virus Hemagglutinin-based Synthetic Peptide: Implications of Critical Glycine Residue in Fusion Peptide Biophys. Chem. 1999; 79: 153–162
- Düzgünes N., Shavnin S.A. Membrane Destabilization by N-Terminal Peptides of Viral Envelope Proteins. J. Membr. Biol. 1992; 128: 71–80
- Pichon C., Freulon I., Midoux P., Mayer R., Monsigny M., Roche A.C. Cytosolic and Nuclear Delivery of Oligonucleotides Mediated by an Amphiphilic Anionic Peptide. Antisense Nucleic Acid Drug Dev. 1997; 7: 335–343
- Freulon I., Roche A.C., Monsigny M., Mayer R. Delivery of Oligonucleotides into Mammalian Cells by Anionic Peptides: Comparison Between Monomeric and Dimeric Peptides. Biochem J. 2001; 354: 671–679
- Plank C., Zauner W., Wagner E. Application of Membrane-active Peptides for Drug and Gene Delivery Across Cellular Membranes. Adv. Drug Del. Rev. 1998; 34: 21–35
- Kichler A., Mechtler K., Behr J.P., Wagner E. Influence of Membrane-Active Peptides on Lipospermine/DNA Complex Mediated Gene Transfer. Bioconjug. Chem. 1997; 8: 213–221
- Wagner E., Plank C., Zatloukal K., Cotten M., Birnstiel M.L. Influenza Virus Hemagglutinin HA-2 N-terminal Fusogenic Peptides Augment Gene Transfer by Transferrin-Polylysine-DNA Complexes: Toward a Synthetic Virus-like Gene-Transfer Vehicle. Proc. Natl. Acad. Sci. USA 1992; 89: 7934–7938